LaBarge MA. The difficulty of targeting cancer stem cell niches. Clin Cancer Res. 2010;16(12):3121–9.

CAS  PubMed  PubMed Central  Google Scholar 

Mora-Blanco EL, Lorens JB, Labarge MA. The tumor microenvironment as a transient niche: a modulator of epigenetic states and stem cell functions. In: Resende RR, Ulrich H, editors. Trends in stem cell proliferation and Cancer research. 1st ed. Dordrecht: Springer; 2013. p. 463–78.

Google Scholar 

dos Santos RV, da Silva LM. The noise and the KISS in the cancer stem cells niche. J Theor Biol. 2013;335:79–87.

PubMed  Google Scholar 

Echeverria GV, Ge Z, Seth S, Zhang X, Jeter-Jones S, Zhou X, et al. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med. 2019;11(488):eaav0936. https://doi.org/10.1126/scitranslmed.aav0936.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546(7658):431–5.

CAS  PubMed  PubMed Central  Google Scholar 

• Jokela TA, Engelsen AST, Rybicka A, Pelissier Vatter FA, Garbe JC, Miyano M, et al. Microenvironment-induced non-sporadic expression of the AXL and cKIT receptors are related to epithelial plasticity and drug resistance. Front Cell Dev Biol. 2018;6:41 Demonstrates that combinatorial microenvironment regulates CSC marker expression, which is correlated with tolerance to chemotherapeutics.

PubMed  PubMed Central  Google Scholar 

•• Lin CH, Jokela T, Gray J, Labarge MA. Combinatorial microenvironments impose a continuum of cellular responses to a single pathway-targeted anti-cancer compound. Cell Rep. 2017;21(2):533–45 Demonstrates synergistic effects of mechanical forces and ECM-composition in imposing drug tolerant states in multiple cancer cell lines.

CAS  PubMed  PubMed Central  Google Scholar 

Senthebane DA, Rowe A, Thomford NE, Shipanga H, Munro D, Mazeedi MAMA, et al. The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer. Int J Mol Sci. 2017;18(7):1586. https://doi.org/10.3390/ijms18071586.

CAS  Article  Google Scholar 

Li Y, Fanous MJ, Kilian KA, Popescu G. Quantitative phase imaging reveals matrix stiffness-dependent growth and migration of cancer cells. Sci Rep. 2019;9(1):248. -018-36551-5.

PubMed  PubMed Central  Google Scholar 

Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241–54.

CAS  PubMed  Google Scholar 

Tian B, Luo Q, Ju Y, Song G. A soft matrix enhances the cancer stem cell phenotype of HCC cells. Int J Mol Sci. 2019;20(11):2831. https://doi.org/10.3390/ijms20112831.

CAS  Article  PubMed Central  Google Scholar 

Hui L, Zhang J, Ding X, Guo X, Jiang X. Matrix stiffness regulates the proliferation, stemness and chemoresistance of laryngeal squamous cancer cells. Int J Oncol. 2017;50(4):1439–47.

CAS  PubMed  Google Scholar 

Jabbari E, Sarvestani SK, Daneshian L, Moeinzadeh S. Optimum 3D matrix stiffness for maintenance of cancer stem cells is dependent on tissue origin of cancer cells. PLoS One. 2015;10(7):e0132377.

PubMed  PubMed Central  Google Scholar 

Yu Q, Xue Y, Liu J, Xi Z, Li Z, Liu Y. Fibronectin promotes the malignancy of glioma stem-like cells via modulation of cell adhesion, differentiation. Proliferation and Chemoresistance Front Mol Neurosci. 2018;11:130.

PubMed  Google Scholar 

Wu X, Cai J, Zuo Z, Li J. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway. Biomed Pharmacother. 2019;114:108708.

CAS  PubMed  Google Scholar 

Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene. 2001;20(36):4995–5004.

CAS  PubMed  Google Scholar 

Vaidyanath A, Mahmud HB, Khayrani AC, Oo AKK, Seno A, Asakura M, et al. Hyaluronic acid mediated enrichment of CD44 expressing glioblastoma stem cells in U251MG xenograft mouse model. J Stem Cell Res Ther 2017;7(384):2.

Sukowati CHC, Anfuso B, Fiore E, Ie SI, Raseni A, Vascotto F, et al. Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis. Sci Rep. 2019;9(1):4026 -019-40436-6.

PubMed  PubMed Central  Google Scholar 

Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD, Farrar WL. Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells. 2010 Mar 31;28(3):390–8.

CAS  PubMed  PubMed Central  Google Scholar 

Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med. 2009;15(9):1010–2.

CAS  PubMed  Google Scholar 

Rice AJ, Cortes E, Lachowski D, Cheung BCH, Karim SA, Morton JP, et al. Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis. 2017;6(7):e352.

CAS  PubMed  PubMed Central  Google Scholar 

Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, et al. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol. 2015;17(5):678–88.

CAS  PubMed  PubMed Central  Google Scholar 

Tzanakakis G, Kavasi RM, Voudouri K, Berdiaki A, Spyridaki I, Tsatsakis A, et al. Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon. Dev Dyn. 2018;247(3):368–81.

PubMed  Google Scholar 

Scott LE, Weinberg SH, Lemmon CA. Mechanochemical signaling of the extracellular matrix in epithelial-mesenchymal transition. Front Cell Dev Biol. 2019;7:135.

PubMed  PubMed Central  Google Scholar 

Snyder V, Reed-Newman TC, Arnold L, Thomas SM, Anant S. Cancer stem cell metabolism and potential therapeutic targets. Front Oncol. 2018;8:203.

PubMed  PubMed Central  Google Scholar 

DelNero P, Hopkins BD, Cantley LC, Fischbach C. Cancer metabolism gets physical. Sci Transl Med. 2018;10(442):eaaq1011. https://doi.org/10.1126/scitranslmed.aaq1011.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Park JS, Burckhardt CJ, Lazcano R, Solis LM, Isogai T, Li L, et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature. 2020;578(7796):621–6.

CAS  PubMed  PubMed Central  Google Scholar 

Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234–40.

CAS  PubMed  PubMed Central  Google Scholar 

Wei L, Yin F, Zhang W, Li L. STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer. Medicine (Baltimore). 2017;96(12):e6345.

CAS  Google Scholar 

Haining AWM, Rahikainen R, Cortes E, Lachowski D, Rice A, von Essen M, et al. Mechanotransduction in talin through the interaction of the R8 domain with DLC1. PLoS Biol. 2018;16(7):e2005599.

PubMed  PubMed Central  Google Scholar 

Goult BT, Yan J, Schwartz MA. Talin as a mechanosensitive signaling hub. J Cell Biol. 2018;217(11):3776–84.

CAS  PubMed  PubMed Central  Google Scholar 

Changede R, Sheetz M. Integrin and cadherin clusters: a robust way to organize adhesions for cell mechanics. Bioessays. 2017;39(1):1–12.

CAS  PubMed  Google Scholar 

Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7(8):e2337.

CAS  PubMed  PubMed Central  Google Scholar 

Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, et al. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, notch and EGFR signaling pathways. Mol Cancer. 2017;16(1):57–017-0621-z.

Google Scholar 

Elfenbein A, Simons M. Syndecan-4 signaling at a glance. J Cell Sci. 2013;126(Pt 17):3799–804.

CAS  PubMed  PubMed Central  Google Scholar 

Voyvodic PL, Min D, Liu R, Williams E, Chitalia V, Dunn AK, et al. Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow. J Biol Chem. 2014;289(14):9547–59.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Brown RL, Wei Y, Zhao P, Liu S, Liu X, et al. CD44 splice isoform switching determines breast cancer stem cell state. Genes Dev. 2019;33(3–4):166–79.

CAS  PubMed  PubMed Central  Google Scholar 

Wobus M, Rangwala R, Sheyn I, Hennigan R, Coila B, Lower EE, et al. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol. 2002;10(1):34–9.

CAS  PubMed  Google Scholar 

Wang SJ, Bourguignon LYW. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132(7):771–8.

PubMed  Google Scholar 

Jokela T, Oikari S, Takabe P, Rilla K, Kärnä R, Tammi M, et al. Interleukin-1beta-induced reduction of CD44 Ser-325 phosphorylation in human epidermal keratinocytes promotes CD44 homomeric complexes, binding to ezrin, and extended. Monocyte-adhesive Hyaluronan Coats J Biol Chem. 2015;290(19):12379–93.

CAS  PubMed  Google Scholar 

Neisch AL, Fehon RG. Ezrin, radixin and moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol. 2011;23(4):377–82.

CAS  PubMed  PubMed Central  Google Scholar 

Tai YL, Chen LC, Shen TL. Emerging roles of focal adhesion kinase in cancer. Biomed Res Int. 2015;2015:690690.

PubMed